The relationship of sputum eosinophilia and sputum cell generation of IL-5.
暂无分享,去创建一个
Lin Ying Liu | W. Busse | H. Kita | E. A. Kelly | L. Liu | C. Swensen | Hirohito Kita | Elizabeth A. B. Kelly | W. W. Busse | Cheri A. Swensen
[1] P. Foster,et al. The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity1 , 2000, The Journal of Immunology.
[2] K. Chung,et al. Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.
[3] P. O'Byrne,et al. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. , 1999, American journal of respiratory and critical care medicine.
[4] I. Pavord,et al. Increases in eotaxin‐positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge , 1999, Allergy.
[5] M. Lampinen,et al. The role of interleukin‐5, interleukin‐8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[6] E. Minshall,et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. , 1999, The Journal of allergy and clinical immunology.
[7] E. Minshall,et al. IL-4 and IL-5 mRNA expression in induced sputum of asthmatic subjects: comparison with bronchial wash. , 1999, The Journal of allergy and clinical immunology.
[8] W. Busse,et al. Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. , 1999, American journal of respiratory and critical care medicine.
[9] P. O'Byrne,et al. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. , 1998, The European respiratory journal.
[10] H. Xu,et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. , 1998, American journal of respiratory and critical care medicine.
[11] W. Busse,et al. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. , 1997, American journal of respiratory and critical care medicine.
[12] Q. Hamid,et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. , 1997, Journal of immunology.
[13] F. Hargreave,et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. , 1997, American journal of respiratory and critical care medicine.
[14] W. Busse,et al. The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. , 1997, American journal of respiratory and critical care medicine.
[15] P. Barnes,et al. Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum. , 1997, The Journal of allergy and clinical immunology.
[16] P. Foster,et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.
[17] F. Hargreave,et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.
[18] H. Kita,et al. Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. , 1996, The Journal of allergy and clinical immunology.
[19] B. Dewald,et al. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.
[20] K. Asano,et al. Cytokine concentrations in sputum of asthmatic patients. , 1996, International archives of allergy and immunology.
[21] R. Egan,et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. , 1995, American journal of respiratory and critical care medicine.
[22] H. Boushey,et al. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. , 1993, The American review of respiratory disease.
[23] P. Forsythe,et al. RANTES is a chemotactic and activating factor for human eosinophils. , 1993, Journal of immunology.
[24] W. Busse,et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. , 1993, The American review of respiratory disease.
[25] I. van Ark,et al. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. , 1993, The American review of respiratory disease.
[26] R. Schweizer,et al. Modulation of eosinophil chemotaxis by interleukin-5. , 1992, American journal of respiratory cell and molecular biology.
[27] S. Durham,et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.
[28] W. Busse,et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. , 1991, The American review of respiratory disease.
[29] V. Brusasco,et al. Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. , 1991, The American review of respiratory disease.
[30] R. Kyle,et al. IgA-induced eosinophil degranulation. , 1989, Journal of immunology.